What metrics would you use to evaluate naviHealth's readmission prevention program?

Introduction

Evaluating naviHealth's readmission prevention program requires a comprehensive approach to product success metrics. To address this challenge effectively, I'll follow a structured framework that covers core metrics, supporting indicators, and risk factors while considering all key stakeholders. This approach will help us assess the program's effectiveness in reducing hospital readmissions and improving patient outcomes.

Step 1

Product Context

naviHealth's readmission prevention program is a healthcare solution designed to reduce hospital readmissions by providing post-acute care management and coordination. The program targets patients who are at high risk of being readmitted to the hospital within 30 days of discharge.

Key stakeholders include:

1. Patients: Seeking improved health outcomes and avoiding unnecessary hospitalizations
2. Hospitals: Aiming to reduce readmission rates and associated penalties
3. Healthcare providers: Looking to improve care coordination and patient outcomes
4. Insurance companies: Interested in reducing healthcare costs
5. naviHealth: Focused on program effectiveness and business growth

User flow:

1. Patient discharge: Hospital identifies high-risk patients for the program
2. Enrollment: Patients are enrolled in the naviHealth program
3. Assessment: naviHealth conducts a comprehensive patient assessment
4. Care planning: A personalized care plan is developed
5. Coordination: naviHealth coordinates care with providers and community resources
6. Monitoring: Ongoing patient monitoring and support is provided
7. Follow-up: Regular check-ins and adjustments to the care plan as needed

The program aligns with the broader healthcare industry trend towards value-based care and reducing unnecessary healthcare costs. Compared to competitors like Aetna's Transitional Care Program or Humana's Hospital to Home program, naviHealth's solution may offer more comprehensive post-acute care management and data-driven decision support.

Product Lifecycle Stage: The readmission prevention program is likely in the growth stage, as the healthcare industry continues to focus on reducing readmissions and improving care transitions. There's still significant potential for expansion and refinement of the program.